In the early and mid-1980s, scientists used phages to express recombinant proteins. The protein was retained inside the virions, so screening required growing viral plaques, creating a stamp of these ...
Co announces that they have licensed their antibody phage display libraries to Cambridge Antibody Technology, a wholly-owned subsidiary of AstraZeneca (AZN), for the discovery of therapeutic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results